Schramm W, Spannagl M, Bauer K A, Rosenberg R D, Birkner B, Linnau Y, Schwarz H P
Medizinische Klinik Innenstadt, University of Munich, Germany.
Arch Dermatol. 1993 Jun;129(6):753-6.
BACKGROUND AND DESIGN--Protein C is a vitamin K-dependent plasma protein that is converted to the serine protease activated protein C by the thrombin-thrombomodulin complex. Activated protein C functions as a natural anticoagulant by inactivating the cofactors of the coagulation cascade, factors Va and VIIIa. Coumarin (warfarin)-induced skin necrosis is thought to be due to a rapid elimination of protein C relative to other vitamin K-dependent factors during the initial phase of oral anticoagulation. We have used a highly purified protein C concentrate to treat a patient with acquired protein C deficiency who developed skin necrosis during the initial phase of oral anticoagulant therapy. OBSERVATIONS AND CONCLUSIONS--During protein C concentrate therapy, no further skin lesions appeared, and the healing process of necrotic areas was facilitated. Replacement therapy with protein C concentrate appears to be safe and effective as an adjunctive treatment for coumarin-induced skin necrosis.
背景与设计——蛋白C是一种维生素K依赖的血浆蛋白,它被凝血酶 - 血栓调节蛋白复合物转化为丝氨酸蛋白酶活化蛋白C。活化蛋白C通过使凝血级联反应的辅因子因子Va和VIIIa失活而发挥天然抗凝剂的作用。香豆素(华法林)诱导的皮肤坏死被认为是由于在口服抗凝治疗的初始阶段,相对于其他维生素K依赖因子,蛋白C被快速清除。我们使用高纯度蛋白C浓缩物治疗一名获得性蛋白C缺乏症患者,该患者在口服抗凝治疗初始阶段出现了皮肤坏死。观察与结论——在蛋白C浓缩物治疗期间,未出现进一步的皮肤病变,坏死区域的愈合过程得到促进。蛋白C浓缩物替代疗法作为香豆素诱导的皮肤坏死的辅助治疗似乎是安全有效的。